Autophagy Modulation in Human Thyroid Cancer Cells following Aloperine Treatment

Area of Science:

• Pharmacology
• Molecular Biology
• Oncology

Background:

• Aloperine, derived from *Sophora alopecuroides*, possesses diverse pharmacological properties.
• Previous research highlighted aloperine's antitumor effects and apoptosis induction in thyroid cancer via the Akt pathway.
• The role of aloperine in modulating autophagy in thyroid cancer, particularly multidrug-resistant types, remained unexplored.

Purpose of the Study:

• To investigate the effect of aloperine on the autophagy mechanism in multidrug-resistant human papillary and anaplastic thyroid cancer cells.
• To elucidate the underlying signaling pathways involved in aloperine-induced autophagy modulation.
• To explore the specific role of the Akt signaling pathway in this process.

Main Methods:

• Incubation of multidrug-resistant human thyroid cancer cell lines with aloperine.
• Analysis of autophagy modulation.
• Investigation of signaling pathways including AMPK, Erk, JNK, p38, and Akt.

Main Results:

• Aloperine treatment modulated the autophagy mechanism in multidrug-resistant papillary and anaplastic human thyroid cancer cells.
• Key signaling pathways, including AMPK, Erk, JNK, p38, and Akt, were implicated in aloperine's effects.
• The Akt signaling pathway was identified as a crucial mediator in aloperine-modulated autophagy.

Conclusions:

• Aloperine exhibits a previously unrecognized function in modulating autophagy in human thyroid cancer cells.
• These findings suggest aloperine as a potential therapeutic agent for targeting autophagy in drug-resistant thyroid cancers.
• Further research into aloperine's mechanisms could lead to novel treatment strategies for thyroid cancer.